Loring Wolcott & Coolidge Fiduciary Advisors LLP MA boosted its stake in UnitedHealth Group Incorporated (NYSE: UNH – Get Rating) by 1.0% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,435 shares of the healthcare conglomerate’s stock after buying an additional 34 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in UnitedHealth Group were worth $ 1,752,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. New World Advisors LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at about $ 319,000. MFA Wealth Advisors LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at about $ 126,000. Studio Investment Management LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at about $ 3,534,000. Garde Capital Inc. lifted its holdings in UnitedHealth Group by 85.7% in the 3rd quarter. Garde Capital Inc. now owns 828 shares of the healthcare conglomerate’s stock valued at $ 324,000 after acquiring an additional 382 shares during the last quarter. Finally, Wealthsource Partners LLC lifted its holdings in UnitedHealth Group by 14.4% in the 3rd quarter. Wealthsource Partners LLC now owns 6,490 shares of the healthcare conglomerate’s stock valued at $ 2,536,000 after acquiring an additional 817 shares during the last quarter. Hedge funds and other institutional investors own 87.48% of the company stock.
In related news, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $ 478.96, for a total value of $ 1,197,400.00. Following the transaction, the director now owns 1,215,000 shares in the company, valued at approximately $ 581,936,400. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Frederick William Mcnabb III acquired 89 shares of the company stock in a transaction dated Thursday, May 26th. The shares were bought at an average price of $ 504.32 per share, for a total transaction of $ 44,884.48. Following the acquisition, the director now owns 11,259 shares in the company, valued at approximately $ 5,678,138.88. The disclosure for this purchase can be found here. Company insiders own 0.40% of the company stock.
UnitedHealth Group stock opened at $ 499.81 on Friday. The company has a market capitalization of $ 468.91 billion, a P / E ratio of 27.36, a P / E / G ratio of 1.50 and a beta of 0.83. The firm’s fifty day simple moving average is $ 495.86 and its 200-day simple moving average is $ 491.14. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.54. UnitedHealth Group Incorporated has a 1-year low of $ 383.12 and a 1-year high of $ 553.29.
UnitedHealth Group (NYSE: UNH – Get Rating) last released its quarterly earnings results on Thursday, April 14th. The healthcare conglomerate reported $ 5.49 earnings per share for the quarter, beating analysts’ consensus estimates of $ 5.40 by $ 0.09. The business had revenue of $ 80.15 billion for the quarter, compared to the consensus estimate of $ 78.77 billion. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. UnitedHealth Group’s revenue for the quarter was up 14.2% on a year-over-year basis. During the same quarter last year, the firm earned $ 5.31 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 28th. Investors of record on Monday, June 20th will be issued a $ 1.65 dividend. This represents a $ 6.60 annualized dividend and a yield of 1.32%. The ex-dividend date of this dividend is Thursday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $ 1.45. UnitedHealth Group’s dividend payout ratio (DPR) is 36.12%.
A number of analysts have commented on the stock. Truist Financial upped their price objective on shares of UnitedHealth Group from $ 575.00 to $ 610.00 in a research note on Thursday, April 7th. Cowen raised their price objective on shares of UnitedHealth Group from $ 512.00 to $ 596.00 in a research note on Monday, April 18th. Cowen raised their price objective on shares of UnitedHealth Group from $ 512.00 to $ 596.00 in a research note on Monday, April 18th. Raymond James raised their price objective on shares of UnitedHealth Group from $ 540.00 to $ 620.00 and gave the stock a “strong-buy” rating in a research note on Tuesday, April 19th. Finally, Wells Fargo & Company reduced their price target on shares of UnitedHealth Group from $ 613.00 to $ 612.00 and set an “overweight” rating for the company in a research note on Wednesday, May 25th. Three analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $ 555.73.
About UnitedHealth Group: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Further Reading:
Receive News & Ratings for UnitedHealth Group Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.
.